Latest: MPS Ltd Q1 FY27 (Apr–Jun 2026) results →This page is Q3 FY26 (Oct–Dec 2025).All Q3 FY26 results →
M

MPS Ltd

Q3 FY26Printing & Publication

MPS Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management said on revenue, margins and capex.

Price₹2,898
Market cap₹4.9K Cr
P/E26.8
Updated23 Aug 2026
Read4 min read

The short version

Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits. MPS aims for 20%-25% year-on-year growth; PBT CAGR of 21% since FY’21. - Target revenue of INR 1500 crores at similar margins within a few years. - Growth driven by a blend of organic and inorganic strategies; acquisitions constitute ~60% of growth plan. - Segment revenue expected to evolve to approx.

From MPS Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits.
  • The company aims to double Unbound's revenue over the next few years by expanding into new geographies such as Southeast Asia, the Middle East, Europe, and Australia.
  • The global healthcare AI and knowledge management market is projected to grow significantly, with the AI-driven knowledge management subsector expected to expand from $3 billion to $102 billion by 2034 at a 42% CAGR.
  • MPS targets an overall growth rate of 20%-25% year-on-year, blending organic and inorganic routes, with acquisitions comprising about 60% of growth strategy.

2 more points from MPS Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what MPS Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • MPS Limited expects significant capital outflow over the next 6 to 12 months related to current investments and acquisitions.
  • The company shows an appetite for growth through acquisitions, with about 60% of its growth strategy relying on inorganic growth.
  • Recent acquisitions like Unbound Medicine involve investments planned to grow the business significantly, including geographic expansion.
  • MPS raised INR 42 crores of debt for the Unbound Medicine acquisition but remains comfortable with this debt level.
  • Capital distribution through dividends or buybacks will continue if there is surplus capital and depending on board decisions, considering expected capital outflows.

2 more points from MPS Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Printing & Publication

Ranked on what management guided this quarter

Guidance-ranked
1Dachepalli Pub.
Rev 2Mar 3
Rev 3Mar 1
3
Rev 3Mar 3
Sign up free to see 1 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what MPS Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what MPS Ltd said on order book & pipeline — free account, 30 seconds.

MPS Ltd — Quarterly revenue & net profit

Revenue Net profit
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27

Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹224 Cr, net profit ₹50 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Printing & Publication this season

  • Repro India (Q3 FY26)

    Q3 FY26 Digital Business revenue: ~ Rs 98.4 crore, up 14% YoY (Pages 4, 29, 44) . Key investor presentation takeaways from Repro India Ltd's Q3 FY26 investor pr

  • Dachepalli Pub. (Q3 FY26)

    90% to 95% of the business (textbook sales) occurs in Q4 and Q1 due to academic calendar seasonality. Key concall takeaways from Dachepalli Publishers Ltd's Q3…

  • S Chand & Compan (Q3 FY26)

    Historically, syllabus changes have resulted in 15%-20% growth over 2-3 years; this time growth is normalized due to gradual implementation. Key concall…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

MPS Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were MPS Ltd Q3 FY26 results?

Unbound's revenues currently have over 60% contribution from North America; future growth will come predominantly from markets outside North America, with North America growing at single digits. MPS aims for 20%-25% year-on-year growth; PBT CAGR of 21% since FY’21. - Target revenue of INR 1500 crores at similar margins within a few years. - Growth driven by a blend of organic and inorganic strategies; acquisitions constitute ~60% of growth plan. - Segment revenue expected to evolve to approx.

What is MPS Ltd share price analysis?

MPS Ltd currently shows a neutral. The stock trades at a P/E of 26.8 with a market cap of ₹4,916 Cr. Investors should review the full earnings analysis for detailed insights.

Is MPS Ltd planning capital expenditure?

MPS Limited expects significant capital outflow over the next 6 to 12 months related to current investments and acquisitions.

Keep MPS Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.